5. Patents and the Right to Health
6. TRIPS
6.1 Introduction
6.2 Enforcement
6.3 TRIPS Flexibilities
6.3.1 Introduction
6.3.2 Article 30
6.3.3 Article 31
6.4 Difficulties inherent in the TRIPS Agreement
6.5 The Doha Declaration
6.6 Parallel importation and the Ministerial Decision of 30 August
6.7 Effect of compulsory licensing on availability of medicines
6.8 TRIPS plus
6.9 Summary on TRIPS and its flexibilities
7. Legal Protection of Health and Intellectual Property in the Egyptian Legal System
7.1 Egypt's Obligation to Protect the Right to Health
7.2 Registration of Medicines
7.3 Price controls and importation of drugs
8. Patent protection in Egypt
8.1 The new patent law and health
9. The Effect of TRIPS Compliance on the Right to Health in Egypt
10. Conclusion and Recommendations
11. Appendix
11.1 Relevant Provisions from the Agreement on Trade-Related Aspects
of Intellectual Property Rights (TRIPS)
11.2 The WTO Declaration on the TRIPS Agreement and Public Health
(The Doha Declaration)
11.3 Implementation of paragraph 6 of the Doha Declaration on the TRIPS Agreement and public health: Decision of the General Council of 30 August 2003
11.4 The General Council Chairperson’s statement accompanying the 30 August 2003 Ministerial Decision
11.5 Relevant Provisions of Law No. 82/2002 on the Protection of Intellectual Property Rights
11.6 Relevant Provisions of the Executive Statutes of Law No. 82/2002 on the Protection of Intellectual Property Rights
